Author:
Sanie-Jahromi Fatemeh,Azimi Ali,Hassanipour Hamidreza,Bostanian Pardis,Khademi Behzad
Funder
Shiraz University of Medical Sciences
Reference34 articles.
1. The pathophysiology and treatment of glaucoma: a review;Weinreb;JAMa,2014
2. The role of retinal ganglion cell structure and function in glaucoma;Feng;Cells,2023
3. Current and new pharmacotherapeutic approaches for glaucoma;Shalaby;Expert. Opin. PharmacOther,2020
4. Travoprost intraocular implant (iDoseTR®) delivers therapeutically relevant and durable aqueous humor drug concentration levels at 12 months and demonstrates safety of implant repeat dosing;Szekely;Invest. Ophthalmol. Vis. Sci.,2023
5. Recently approved drugs for lowering and controlling intraocular pressure to reduce vision loss in ocular hypertensive and glaucoma patients;Sharif;Pharmaceuticals,2023